Cyclic Poly(2-methyl-2-oxazoline)-Lipid Conjugates Are Good Alternatives to Poly(ethylene glycol)-Lipids for Lipid Nanoparticle mRNA Formulation

Feb 19, 2025Biomacromolecules

Cyclic Poly(2-methyl-2-oxazoline)-Lipid Compounds as Effective Alternatives to Poly(ethylene glycol)-Lipids in Lipid Nanoparticles for mRNA Delivery

AI simplified

mRNA Technology on OpenScience ↗PubMed ↗DOI ↗

Abstract

Cyclic PMOXA conjugates may surpass the performance of PEG-based analogues in mRNA lipid nanoparticles.

Poly(ethylene glycol) (PEG) lipids can trigger anti-PEG antibodies, leading to accelerated blood clearance and reduced therapeutic effectiveness.
Poly(2-methyl-2-oxazoline) (PMOXA) was explored as a stabilizing agent for mRNA lipid nanoparticles.
The study synthesized both cyclic and linear PMOXA and evaluated their effects on lipid nanoparticles' properties.
In vitro assessments showed differences in cellular uptake, transfection efficiency, and protein corona formation between PMOXA and PEG stabilizers.
In vivo experiments indicated that cyclic PMOXA conjugates demonstrated promising biodistribution and protein translation efficiency.

AI simplified

Lipid nanoparticles (LNPs) with ionizable cationic lipids have revolutionized RNA drug delivery, playing a key role in the success of mRNA-based therapeutics, such as COVID-19 vaccines. A vital component of these LNPs is the poly(ethylene glycol) (PEG)-lipid conjugate, which enhances colloidal stability but may trigger the production of anti-PEG antibodies, resulting in accelerated blood clearance (ABC) and diminished therapeutic efficacy. In this study, we explored poly(2-methyl-2-oxazoline) (PMOXA) as an alternative stabilizing agent for mRNA LNPs. We synthesized both cyclic and linear PMOXA, conjugated them to dialkyl lipids, and created lipid-polymer amphiphiles. We systematically evaluated how polymer topology influenced the physicochemical properties of LNPs, including in vitro cellular uptake, transfection efficiency, and protein corona formation, and directly compared these properties with those of PEG-stabilized counterparts. In vivo experiments in mice further assessed the biodistribution and protein translation efficiency of these LNPs following intravenous administration. Our results showed that cyclic PMOXA conjugates not only matched but potentially surpassed the performance of PEG-based analogues, highlighting their promise as a superior alternative in mRNA-LNP formulations.

Full Text

Full text is available at the source.

View full text (PDF) ↗View full text ↗

Cyclic Poly(2-methyl-2-oxazoline)-Lipid Conjugates Are Good Alternatives to Poly(ethylene glycol)-Lipids for Lipid Nanoparticle mRNA Formulation

Abstract

Full Text

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief

Abstract

Full Text

Related papers

You found one interesting study. We’ll send the next 7.

what lands in your inbox each week:

Recent issues from the mrna technology brief